gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro
- PMID: 12499219
- PMCID: PMC148966
- DOI: 10.1128/AAC.47.1.383-386.2003
gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro
Abstract
We isolated and characterized mutants of Bartonella bacilliformis that are resistant to the fluoroquinolone antibiotic ciprofloxacin, which targets the A subunit of DNA gyrase. Mutants had single point mutations in the gyrA gene that changed either Asp-90 to Gly or Asp-95 to Asn and had 3- or 16-fold higher resistance, respectively, to ciprofloxacin than did wild-type B. bacilliformis. Asp-95 is homologous to Asp-87 of Escherichia coli GyrA and is a common residue mutated in fluoroquinolone-resistant strains of other bacteria. This is the first report of a mutation at an Asp-90 homologue, which corresponds to Asp-82 in E. coli GyrA.
Figures


Similar articles
-
Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.Antimicrob Agents Chemother. 1998 Nov;42(11):2906-13. doi: 10.1128/AAC.42.11.2906. Antimicrob Agents Chemother. 1998. PMID: 9797224 Free PMC article.
-
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.J Urol. 2000 Sep;164(3 Pt 1):847-51. doi: 10.1097/00005392-200009010-00060. J Urol. 2000. PMID: 10953166
-
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.J Clin Microbiol. 1997 Sep;35(9):2315-9. doi: 10.1128/jcm.35.9.2315-2319.1997. J Clin Microbiol. 1997. PMID: 9276409 Free PMC article.
-
Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.Am J Med. 1989 Nov 30;87(5A):2S-8S. doi: 10.1016/0002-9343(89)90010-7. Am J Med. 1989. PMID: 2574005
-
In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.Chemotherapy. 2004 Dec;50(6):265-75. doi: 10.1159/000082624. Epub 2004 Dec 8. Chemotherapy. 2004. PMID: 15608441
Cited by
-
Whole Genome Sequencing and Comparative Analysis of Bartonella bacilliformis Strain INS, the Causative Agent of Carrion's Disease.Genome Announc. 2013 Jan;1(1):e00053-12. doi: 10.1128/genomeA.00053-12. Epub 2013 Feb 14. Genome Announc. 2013. PMID: 23409255 Free PMC article.
-
Carrion's Disease: the Sound of Silence.Clin Microbiol Rev. 2017 Nov 29;31(1):e00056-17. doi: 10.1128/CMR.00056-17. Print 2018 Jan. Clin Microbiol Rev. 2017. PMID: 29187394 Free PMC article. Review.
-
Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for elimination.PLoS Negl Trop Dis. 2012;6(10):e1819. doi: 10.1371/journal.pntd.0001819. Epub 2012 Oct 25. PLoS Negl Trop Dis. 2012. PMID: 23145188 Free PMC article.
-
A Review of Scrub Typhus (Orientia tsutsugamushi and Related Organisms): Then, Now, and Tomorrow.Trop Med Infect Dis. 2018 Jan 17;3(1):8. doi: 10.3390/tropicalmed3010008. Trop Med Infect Dis. 2018. PMID: 30274407 Free PMC article. Review.
-
Studies on the antimicrobial properties of N-acylated ciprofloxacins.Bioorg Med Chem Lett. 2012 Oct 15;22(20):6513-20. doi: 10.1016/j.bmcl.2012.05.026. Epub 2012 Jul 1. Bioorg Med Chem Lett. 2012. PMID: 22995622 Free PMC article.
References
-
- Cuadra, M. S. 1956. Salmonellosis complication in human bartonellosis. Tex. Rep. Biol. Med. 14:97-113. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases